0001127602-23-008815.txt : 20230303 0001127602-23-008815.hdr.sgml : 20230303 20230303172523 ACCESSION NUMBER: 0001127602-23-008815 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230301 FILED AS OF DATE: 20230303 DATE AS OF CHANGE: 20230303 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Shetty Reshma P. CENTRAL INDEX KEY: 0001873523 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-40097 FILM NUMBER: 23705934 MAIL ADDRESS: STREET 1: C/O SOARING EAGLE ACQUISITION CORP. STREET 2: 955 FIFTH AVENUE CITY: NEW YORK STATE: NY ZIP: 10075 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ginkgo Bioworks Holdings, Inc. CENTRAL INDEX KEY: 0001830214 STANDARD INDUSTRIAL CLASSIFICATION: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] IRS NUMBER: 872652913 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 BUSINESS PHONE: (877) 442-5362 MAIL ADDRESS: STREET 1: 27 DRYDOCK AVENUE STREET 2: 8TH FLOOR CITY: BOSTON STATE: MA ZIP: 02210 FORMER COMPANY: FORMER CONFORMED NAME: Soaring Eagle Acquisition Corp. DATE OF NAME CHANGE: 20210210 FORMER COMPANY: FORMER CONFORMED NAME: Spinning Eagle Acquisition Corp. DATE OF NAME CHANGE: 20201027 4 1 form4.xml PRIMARY DOCUMENT X0306 4 2023-03-01 0001830214 Ginkgo Bioworks Holdings, Inc. DNA 0001873523 Shetty Reshma P. C/O GINKGO BIOWORKS HOLDINGS 27 DRYDOCK AVENUE BOSTON MA 02210 1 1 1 See remarks Class A Common Stock 2023-03-01 4 S 0 37650 1.394 D 13955854 D Class A Common Stock 13993494 I By Spouse The shares were sold pursuant to a sales plan adopted by the Reporting Person or the Reporting Person's spouse and intended to comply with Rule 10b5-1 under the Securities Exchange Act of 1934. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $1.33 to $1.475, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth above. President, COO & Founder /s/ Karen Tepichin, Attorney-in-Fact 2023-03-03